China’s leading Biopharma event concludes successfully with 400+ industry attendees
Organised by IBC Asia, the annual Biopharma Development & Production (BDP) Week took place on 16 – 17 May 2018 at Hilton Shanghai Hongqiao Hotel.
Read more
biotech
OBI Pharma announces acquisition of cancer drug candidate from Threshold Pharmaceuticals
Taipei, Taiwan-headquartered OBI Pharma, Inc., (TPex: 4174), announced last week that an agreement with Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) had been made to acquire TH-3424, a first-in-class novel small-molecule prodrug that selectively targets cancers overexpressing the enzyme aldo-keto reductase 1c3 (AKR1C3).
Read more
Taiwan a great location for biotech IPOs, says Aslan Pharma CEO
In an interview with finance website Deal Street Asia, Singapore-headquartered drug development firm Asian Pharmaceuticals’ CEO Dr Carl Firth discussed why he took the company public in Taiwan and not Singapore, Europe or the US.
Read more
US pharma lobby group pushes for better IP protection in Taiwan
A delegation from the Pharmaceutical Research and Manufacturers of America (PhRMA) made a recent visit to Taiwan and while here urged the government to pass laws that would better strengthen intellectual property protection for pharmaceuticals.
Read more
JHL doses first patient In JHL1101 Phase I European trial
JHL Biotech Inc. (Stock Code: 6540.TWO) today announced that the first patient has been dosed in the company’s Phase I clinical trial of JHL1101 (a proposed rituximab biosimilar) in rheumatoid arthritis patients.
Read more
Hon Hai chairman Gou forms Taiwanese, Chinese and US alliance to fight cancer
After his late wife’s battle with breast cancer, Hon Hai Precision Industry chairman and Taiwan’s richest man Terry Gou started the Yonglin Healthcare Foundation, with the aim of using the best of technology wherever it was developed to take the fight to this disease.
Read more